FDA Approves FOSFOMYCIN TROMETHAMINE — Aucta Pharmaceuticals, Inc.
# FDA Approves Generic Fosfomycin Tromethamine, Expanding Treatment Options for Urinary Tract Infections Aucta Pharmaceuticals, Inc. received FDA approval for its generic formulat…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves Generic Fosfomycin Tromethamine, Expanding Treatment Options for Urinary Tract Infections Aucta Pharmaceuticals, Inc. received FDA approval for its generic formulat…
Apotex Corp. has secured FDA approval for its Intravenous Adult Multiple Vitamins pharmacy bulk package, bolstering its commercial portfolio and providing the company with a key gr…
On April 9, 2026, Apotex Corp received FDA approval for a generic Adult Multiple Vitamins single-dose product, a move likely to intensify price competition within the adult multivi…
# FDA Approves Micro Labs' Generic Drug Application Micro Labs has received FDA approval for its abbreviated new drug application (ANDA218557), expanding the company's generic pha…
Hikma Pharmaceuticals USA Inc. received FDA approval for its Abbreviated New Drug Application (ANDA) covering oral Eltrombopag Olamine on April 8, 2026, positioning the company to …
Glenmark Pharmaceuticals USA announced today the approval of its generic progesterone vaginal inserts (ANDA 216363) by the FDA, a critical move to capture market share in the short…
# FDA Approves Generic Ivermectin ANDA from Ajanta Pharma USA Inc. Ajanta Pharma USA Inc. has received FDA approval for its generic ivermectin oral formulation (ANDA218509), expan…
# FDA Approves Creekwood Pharmaceuticals' Generic Nitrofurantoin for Urinary Tract Infections The FDA has approved Creekwood Pharmaceuticals LLC's generic nitrofurantoin monohydra…
Macleods Pharmaceuticals Ltd has received FDA approval for ANDA214216 dated April 7, 2026, signaling a strategic foothold within the pharmaceutical market, subject to planned comme…
# FDA Approves Generic Dapagliflozin from Ajanta Pharma USA The U.S. FDA has approved Ajanta Pharma USA Inc.'s generic version of dapagliflozin, an SGLT2 inhibitor used to treat t…
# FDA Approves CIPLA Generic Drug Application Cipla Limited has received FDA approval for its abbreviated new drug application (ANDA 211595), expanding the company's generic pharm…
# FDA Approves Generic Dapagliflozin; Teva Pharmaceuticals Enters Competitive SGLT2 Inhibitor Market Teva Pharmaceuticals, Inc. received FDA approval for its generic dapagliflozin…
# FDA Approves Teva Pharmaceuticals Generic Drug Application Teva Pharmaceuticals USA Inc. received FDA approval for ANDA 211583 on April 6, 2026, potentially expanding its generi…
# FDA Approves Generic Version of DAPAGLIFLOZIN The U.S. Food and Drug Administration has approved Zydus Lifesciences Limited's generic formulation of dapagliflozin (ANDA211582), …
# FDA Approves ANDA for Micro Labs Micro Labs has received FDA approval for an abbreviated new drug application (ANDA211466), expanding its generic drug portfolio and positioning …
# FDA Approves Generic Dapagliflozin from Florida Pharmaceutical Products The FDA has approved Florida Pharmaceutical Products, LLC's generic formulation of dapagliflozin (ANDA211…
# FDA Approves Generic Dapagliflozin from Macleods Pharmaceuticals The U.S. FDA has approved Macleods Pharmaceuticals Limited's generic version of dapagliflozin, an SGLT2 inhibito…
# FDA Approves Generic Drug Application for Cipla Ltd Cipla Ltd received FDA approval for an abbreviated new drug application (ANDA211536) on April 6, 2026, expanding the company'…
# FDA Approves Generic Version of Dapagliflozin and Saxagliptin Combination Novadoz Pharmaceuticals LLC has received FDA approval for a generic formulation of dapagliflozin and sa…
# FDA Approves Torrent's ANDA Application Torrent Pharmaceuticals has received FDA approval for its abbreviated new drug application (ANDA211537), expanding the company's generic …